stockportfolio.pro
PTC Therapeutics, Inc. Revenue 2011–2025
PTC Therapeutics, Inc. (PTCT) annual revenue by fiscal year, computed from SEC filings. Compound growth +22.1%/yr over 14 years.
| Fiscal year | Revenue | Change (YoY) |
|---|---|---|
| FY 2025 | $1.73B | +114.5% |
| FY 2024 | $806.78M | -14.0% |
| FY 2023 | $937.82M | +34.2% |
| FY 2022 | $698.80M | +29.7% |
| FY 2021 | $538.59M | +41.4% |
| FY 2020 | $380.77M | +24.0% |
| FY 2019 | $306.98M | +16.0% |
| FY 2018 | $264.73M | +36.2% |
| FY 2017 | $194.39M | +135.0% |
| FY 2016 | $82.70M | +124.9% |
| FY 2015 | $36.77M | +45.6% |
| FY 2014 | $25.25M | -27.2% |
| FY 2013 | $34.70M | +2.2% |
| FY 2012 | $33.95M | -67.8% |
| FY 2011 | $105.41M | — |
Source: PTC Therapeutics, Inc. SEC filings — income statement (10-K). Refreshed nightly.
See the full picture for PTC Therapeutics, Inc.
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freePTC Therapeutics, Inc. — frequently asked questions
What is PTC Therapeutics, Inc.'s revenue?
PTC Therapeutics, Inc. (PTCT) reported revenue of $1.73B for fiscal year 2025, per its SEC filings.
How has PTC Therapeutics, Inc.'s revenue changed over time?
Between fiscal 2011 and 2025, PTCT's revenue grew at roughly 22.1% per year (compound annual rate), from $105.41M to $1.73B.
Where does this data come from?
Figures are computed from PTC Therapeutics, Inc.'s official SEC filings (income statement (10-K)), refreshed nightly. Not investment advice.